Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Ferreri, Anna  [Clear All Filters]
Journal Article
Canale FAntonio, Pitea M, Alati C, Porto G, Pratico G, Utano G, Germanò J, Imbalzano L, Ferreri A, Verduci C, et al. Case Report: CAR-T cells and subsequent maintenance with ponatinib in an adult Philadelphia acute lymphoblastic leukemia patient with hematological and extramedullary relapse after allogeneic stem cell transplantation. Eur J Haematol. 2023.
Martino M, Gori M, Moscato T, Naso V, Ferreri A, Provenzano F, Loteta B, Sanguedolce MCristina, Console G, Dattola A, et al. The challenge to predict mobilized peripheral blood stem cells on the fourth day of G-CSF treatment in healthy donors: the predictive value of basal CD34+ cell and platelet counts. Biol Blood Marrow Transplant. 2019.
Martino M, Gori M, Porto G, Pellicano M, Santoro L, Verduci C, Canale FAntonio, Loteta B, Moscato T, Alati C, et al. Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation. Ann Hematol. 2023.
Martino M, Gori M, Porto G, Pellicano M, Santoro L, Verduci C, Canale FAntonio, Loteta B, Moscato T, Alati C, et al. Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation. Ann Hematol. 2023.
Canale FA, Martino M, Porto G, Verduci C, Console G, Irrera G, Loteta B, Naso V, Pugliese M, Moscato T, et al. The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic. Support Care Cancer. 2023;31(6):350.